Real-World Delivery, Dose Adaptation, and Molecular Monitoring of Gilteritinib, Venetoclax, and Azacitidine in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma & Leukemia · Elsevier

Аннотация

Publication date: October 2026 Source: Clinical Lymphoma Myeloma and Leukemia, Volume 26, Issue 10 Author(s): Meiling Chen, Yuanzhong Chen, Shaoyuan Wang, Feng’e Yang, Jing Zheng, Danhui Fu, Jia Lin, Xiaofan Li, Nainong Li

Читать у издателя →

Похожие статьи